Stock Market News

Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong.

wcc wcc
Jul 13, 2026 - 22:15
0 1
Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong.
Previous Article

Starbucks Is Serving Up Your Coffee with a Side of AI. What That Means for SB...

Next Article

The U.S. Economy Is Addicted to AI Spending. What Happens If It Slows?

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
wcc
wcc

Related Posts

The U.S. Economy Is Addicted to AI Spending. What Happens If It Slows?

The U.S. Economy Is Addicted to AI Spending. What Ha...

wcc
Jul 13, 2026
0
1
Fed Chair Kevin Warsh Bets on AI, Taps Marc Andreessen and Xbox CEO Asha Sharma to Help 'Inform' Future Fed Policy

Fed Chair Kevin Warsh Bets on AI, Taps Marc Andreess...

wcc
Jul 13, 2026
0
1
This 8-Word Statement From Fed Chair Kevin Warsh and the FOMC Is a Potential Game Changer for Wall Street

This 8-Word Statement From Fed Chair Kevin Warsh and...

wcc
Jul 13, 2026
0
1

A toxic stew drags stocks lower as we look at what c...

wcc
Jul 13, 2026
0
1
Fed Chair Kevin Warsh Bets on AI, Taps Marc Andreessen and Xbox CEO Asha Sharma to Help 'Inform' Future Fed Policy

Fed Chair Kevin Warsh Bets on AI, Taps Marc Andreess...

wcc
Jul 13, 2026
0
1
Why Most Americans Say They Won’t Save Enough for Retirement, Even After Decades of Work

Why Most Americans Say They Won’t Save Enough for Re...

wcc
Jul 13, 2026
0
1

Comments (0)

User